Eikon Therapeutics (NAS: EIKN)

Millbrae, CA · Founded 2019 · Publicly Held

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet… Eikon Therapeutics (NAS: EIKN) is based in Millbrae, CA and was founded in 2019. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $972 million (Feb 2026). It has raised $1.5 billion.

Last price · $/share
—
Implied valuation
$971.7M
Total raised
$1.5B
Last round
—

Who backs Eikon Therapeutics (NAS: EIKN)?

22 investors
InvestorType
General CatalystVenture capital
Lux CapitalVenture capital
Alexandria Venture InvestmentsOther
StepStone Group—
AME Cloud VenturesVenture capital
Innovation EndeavorsVenture capital
T. Rowe Price Group—
CPP InvestmentsOther
Horizons VenturesVenture capital
Foresite CapitalVenture capital
+ 12 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Eikon Therapeutics (NAS: EIKN) investors

22 investors are on record for Eikon Therapeutics (NAS: EIKN), including General Catalyst, Lux Capital, Alexandria Venture Investments and StepStone Group. By type, the record holds 7 venture capital firms and 1 family office.

Free account
More of Eikon Therapeutics (NAS: EIKN) with a free account
  • ·The complete investor list: 22 names
  • ·Watch Eikon Therapeutics (NAS: EIKN): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 22 firms already write checks for companies like Eikon Therapeutics (NAS: EIKN). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View